We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance on the main diseases that affect cattle, disease prevention and legal controls in place to protect cattle health.
You can claim relief to pay no Customs Duty and VAT if you're importing therapeutic substances of human origin, blood-grouping or tissue-typing reagents, or related packaging, solvents and accessories.
You need to be registered with DARD to transport unmixed restricted or prohibited animal proteins in bulk in Northern Ireland
Information for healthcare professionals and the public about the COVID-19 vaccine Nuvaxovid.
These guidelines set out how we examine patent applications for biotechnological inventions under the Patents Act 1977.
This guideline is to provide developers of biosimilar products with a clear outline of the requirements in Great Britain.
Paper prepared by academics on the viral evolution of COVID-19.
We want your comments on the clarity and wording of our new guidance
The Commission on Human Medicines (CHM) has concluded that the risk of vCJD cases arising from the use of UK plasma for the manufacture of immunoglobulin medicinal products would be negligible.
Information on how to handle undersize fish and what rules apply.
The Medicines and Healthcare products Regulatory Agency (MHRA) has undertaken a further review of the safety of albumins manufactured from UK plasma with respect to vCJD.
Guidance on infant and follow-on formula, the application form for infant and follow-on formula made from protein hydrolysates, and forms to notify the authority.
Sections (4.01 - 4.07.2) last updated January 2024.
A set of principles for understanding the impact of new variants on antiviral drugs and monoclonal antibodies
Record of the discussion that took place at SAGE's sixty-seventh meeting.
Information on the use of human and animal products in vaccines.
Information for healthcare professionals and the public about the Pfizer/BioNTech vaccine.
Advice to the Prime Minister on opportunities to capture economic and social impact from engineering biology.
Information on chromium for use in responding to chemical incidents.
We are seeking scientific comments on SACN’s draft report ‘Feeding young children aged 1 to 5 years’.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).